GBIO

Generation Bio Co.

2.55 USD
-0.15 (-5.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Generation Bio Co. stock is down -24.78% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 4 June’s closed higher than May.

About Generation Bio Co.

Generation Bio Co. develops therapies for the treatment of rare and prevalent diseases. The company was formerly known as Torus Therapeutics, Inc. It focuses on the diseases of skeletal muscle, central nervous system, and oncology.